Clinical Trials Browser

Phase 1 × Breast Neoplasms × soluble LAG-3 protein, human × Clear all

NCT04252768 2023-03-22

AIPAC-002

Phase 1 Withdrawn

Breast Neoplasms

NCT00349934 2010-01-07

IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma

Phase 1 Completed

Breast Neoplasms